Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction?

New England Journal of Medicine

Volumn 335, Issue 17, 1996, Pages 1311-1317

  Lange, R A ^a   Hillis, L D ^a   Grines, C L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; COMPARATIVE STUDY; CORONARY ARTERY DILATATION; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL COMPETENCE; HUMANS; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0029862005     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199610243351710     Document Type: Note

References (0)